TriNetX acquires Custodix

TriNetX said it acquired Custodix, a provider of services for clinical trial design, patient feasibility and more. The financial details of the transaction were not released.

2 April 2019•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail